AddLife AB (publ) (LON: 0REZ)
London
· Delayed Price · Currency is GBP · Price in SEK
144.80
-1.04 (-0.71%)
Jan 23, 2025, 1:41 PM BST
AddLife AB Revenue
AddLife AB had revenue of 2.34B SEK in the quarter ending September 30, 2024, with 1.08% growth. This brings the company's revenue in the last twelve months to 10.01B, up 5.76% year-over-year. In the year 2023, AddLife AB had annual revenue of 9.69B with 6.62% growth.
Revenue (ttm)
10.01B SEK
Revenue Growth
+5.76%
P/S Ratio
n/a
Revenue / Employee
4.35M SEK
Employees
2,301
Market Cap
1.30B GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 9.69B | 601.00M | 6.62% |
Dec 31, 2022 | 9.08B | 1.09B | 13.65% |
Dec 31, 2021 | 7.99B | 2.72B | 51.57% |
Dec 31, 2020 | 5.27B | 1.79B | 51.56% |
Dec 31, 2019 | 3.48B | 997.80M | 40.21% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |